<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Despite anticoagulation for <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, some patients still suffer an ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The issue of whether to stop or continue <z:chebi fb="8" ids="10033">warfarin</z:chebi>, or possibly to reverse the anticoagulation is an area of uncertainty </plain></SENT>
<SENT sid="2" pm="."><plain>Continued anticoagulation may, however, increase haemorrhagic transformation of the <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In this article we review the published evidence in an attempt to quantify the risks and benefits of each treatment strategy and identify areas for further research </plain></SENT>
</text></document>